logo

EbookBell.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link:  https://ebookbell.com/faq 


We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.


For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookBell Team

Biosimulation In Drug Development Martin Bertau Erik Mosekilde

  • SKU: BELL-1124304
Biosimulation In Drug Development Martin Bertau Erik Mosekilde
$ 31.00 $ 45.00 (-31%)

4.0

56 reviews

Biosimulation In Drug Development Martin Bertau Erik Mosekilde instant download after payment.

Publisher: Wiley-VCH
File Extension: PDF
File size: 4.87 MB
Pages: 525
Author: Martin Bertau, Erik Mosekilde, Hans V. Westerhoff
ISBN: 9783527316991, 9783527622689, 352731699X, 3527622683
Language: English
Year: 2007

Product desciption

Biosimulation In Drug Development Martin Bertau Erik Mosekilde by Martin Bertau, Erik Mosekilde, Hans V. Westerhoff 9783527316991, 9783527622689, 352731699X, 3527622683 instant download after payment.

This first comprehensive survey to cover all pharmaceutically relevant topics provides a comprehensive introduction to this novel and revolutionary tool, presenting both concepts and application examples of biosimulated cells, organs and organisms.Following an introduction to the role of biosimulation in drug development, the authors go on to discuss the simulation of cells and tissues, as well as simulating drug action and effect. A further section is devoted to simulating networks and populations, and the whole is rounded off by a look at the potential for biosimulation in industrial drug development and for regulatory decisions.Part of the authors are members of the BioSim Network of Excellence that encompasses more than 40 academic institutions, pharmaceutical companies and regulatory authorities dealing with drug development; other contributors come from industry, resulting in a cross-disciplinary expert reference.

Related Products